İRKEÇ, C. Et Al. 2017. Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet’xxs disease. MULTIPLE SCLEROSIS JOURNAL , (Paris, France), 781-782.

İRKEÇ, C., kuz, t., altıparmak, t., & fıdan, ı., (2017). Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet’xxs disease . MULTIPLE SCLEROSIS JOURNAL (pp.781-782). Paris, France

İRKEÇ, CEYLA Et Al. "Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet’xxs disease," MULTIPLE SCLEROSIS JOURNAL, Paris, France, 2017

İRKEÇ, CEYLA Et Al. "Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet’xxs disease." MULTIPLE SCLEROSIS JOURNAL , Paris, France, pp.781-782, 2017

İRKEÇ, C. Et Al. (2017) . "Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet’xxs disease." MULTIPLE SCLEROSIS JOURNAL , Paris, France, pp.781-782.

@conferencepaper{conferencepaper, author={CEYLA İRKEÇ Et Al. }, title={Fractalkine (CX3CL1) in the sera of patients with multiple sclerosis and Neuro-Behcet’xxs disease}, congress name={MULTIPLE SCLEROSIS JOURNAL}, city={Paris}, country={France}, year={2017}, pages={781-782} }